Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Abiraterone
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Abiraterone 500mg tablets
0803042T0AAABAB
|
Abiraterone | Abiraterone | Malignant Disease and Immunosuppression | 2 |
|
Abiraterone 1g tablets
0803042T0AAACAC
|
Abiraterone | Abiraterone | Malignant Disease and Immunosuppression | No data available |
|
Abiraterone 250mg tablets
0803042T0AAAAAA
|
Abiraterone | Abiraterone | Malignant Disease and Immunosuppression | No data available |
|
Zytiga 250mg tablets
0803042T0BBAAAA
|
Zytiga | Abiraterone | Malignant Disease and Immunosuppression | No data available |
|
Zytiga 500mg tablets
0803042T0BBABAB
|
Zytiga | Abiraterone | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.